Skip to content

Public FDA record

Z-1477-2012: EPIFLO; Transdermal continuous oxygen therapy device; single use; disposable medical device. Model Number

Recall record Z-1477-2012 for Ogenix Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1477-2012
Company in FDA record
Ogenix Corporation
FDA classification date
Apr 30, 2012
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Ogenix Initiated a voluntary recall for the EPIFLO-15 devices due to a mislabeling of the expiry date for this lot. Instead of March 2013, this lot carried May 2013 as the expiry date.

Source facts

Action
Ogenix sent a letter dated March 16, 2012 to all affected customers. The letter identified the product, the problem and the action to be taken by the customer. Customers were instructed to confirm the status of the devices and ship product with the recalled lot back to Ogenix and complete the form provided with the letter.
Initiated
2012-04-16
Root cause
Labeling mix-ups
Terminated
2013-02-19
Distribution
Worldwide Distribution-USA (nationwide) including the states of FL, MN, OH and the county of Turkey.
Recall number
Z-1477-2012
Recall status
Terminated
CDRH record ID
108599
FDA classified
2012-04-30
Recall event number
61635

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗